Beyond Amyloid: New Alzheimer's Treatment Targets Alternative Brain Pathways Introduction Alzheimer's disease, the most common cause of dementia accounting for 60-70% of all cases, requires new Alzheimer's treatment approaches as current strategies show limited efficacy. According to the World Health Organization's 2022 blueprint for
Tag: nano-peptide therapeutics
